Options

Clover Health Investments, Corp. Announces Redemption of All Outstanding Warrants

Retrieved on: 
Thursday, July 22, 2021

In addition, the Company will redeem all of its outstanding warrants to purchase Common Stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO (the Private Warrants and, together with the Public Warrants, the Warrants) on the same terms as the outstanding Public Warrants.

Key Points: 
  • In addition, the Company will redeem all of its outstanding warrants to purchase Common Stock that were issued under the Warrant Agreement in a private placement simultaneously with the IPO (the Private Warrants and, together with the Public Warrants, the Warrants) on the same terms as the outstanding Public Warrants.
  • At the direction of the Company, the Warrant Agent has delivered a notice of redemption to each of the registered holders of the outstanding Warrants.
  • The Warrants may be exercised by the holders thereof until 5:00 p.m. New York City time on the Redemption Date to purchase fully paid and non-assessable shares of Common Stock underlying such Warrants.
  • Clover Health (Nasdaq: CLOV) is a next-generation risk-bearing organization aiming to achieve health equity for all Americans.

Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Retrieved on: 
Thursday, July 22, 2021

The 2018 Equity Inducement Plan is used exclusively for the grant of equity awards to individuals as an inducement material to such individuals entering into employment with Sierra, pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules.

Key Points: 
  • The 2018 Equity Inducement Plan is used exclusively for the grant of equity awards to individuals as an inducement material to such individuals entering into employment with Sierra, pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules.
  • The option has an exercise price of $19.12 per share, which is equal to the closing price of Sierras common stock on the date of grant.
  • The option is subject to the terms and conditions of Sierras 2018 Equity Inducement Plan, and the terms and conditions of the stock option agreement covering the grant.
  • Sierra Oncology is a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer.

DGAP-News: JPMorgan ETFs (Ireland) ICAV: Change to Cboe Europe - UK trading venue (CXE)

Retrieved on: 
Thursday, July 22, 2021

The Management Company is of the opinion that there is nothing contained in this notice nor in the proposals detailed herein that conflicts with the Central Bank UCITS Regulations.

Key Points: 
  • The Management Company is of the opinion that there is nothing contained in this notice nor in the proposals detailed herein that conflicts with the Central Bank UCITS Regulations.
  • Philippe Ringard On behalf of JPMorgan Asset Management (Europe) S. r.l.
  • Please note that JPMorgan Asset Management is currently consolidating the listing of certain ETFs on Cboe Europe and effective Friday 30 July 2021 (the "Change Date"), after the close of the respective exchanges, the below ETF Share Classes will be switched from their current listing on Cboe Europe - UK trading venue (CXE) to Cboe Europe - NL trading venue (DXE).
  • Registered office 200 Capital Dock, 79 Sir John Rogerson's Quay
    Management Company JPMorgan Asset Management (Europe) S. r.l.

Major Precious Metals Completes Final Tranche of $10 Million Private Placement

Retrieved on: 
Thursday, July 22, 2021

VANCOUVER, British Columbia, July 21, 2021 (GLOBE NEWSWIRE) -- Major Precious Metals Corp. ("Major Precious Metals" or the Company) (CSE:SIZE | OTC:SIZYF | FRANKFURT:3EZ) is pleased to announce that it has closed a non-brokered private placement (the Private Placement) of 4,285,715 units of the Company (the Units) at a price of $0.35 per Unit for gross proceeds of $1,500,000.25.

Key Points: 
  • VANCOUVER, British Columbia, July 21, 2021 (GLOBE NEWSWIRE) -- Major Precious Metals Corp. ("Major Precious Metals" or the Company) (CSE:SIZE | OTC:SIZYF | FRANKFURT:3EZ) is pleased to announce that it has closed a non-brokered private placement (the Private Placement) of 4,285,715 units of the Company (the Units) at a price of $0.35 per Unit for gross proceeds of $1,500,000.25.
  • Finders fees of $8,085 cash and 23,100 Warrants have been paid in connection with the Private Placement to qualified parties.
  • One Director of the Company participated in the Private Placement and will acquire, directly or indirectly, 300,000 Units.
  • On July 7, the Company incorrectly advised that finders fees of $340,851 cash and 949,860 Warrants were paid in connection with the first tranche of the Private Placement.

JPMorgan ETFs (Ireland) ICAV Announces Change to Cboe Europe - UK trading venue (CXE)

Retrieved on: 
Wednesday, July 21, 2021

DUBLIN, Ireland, July 21, 2021 (GLOBE NEWSWIRE) -- This notice has not been reviewed by the Central Bank of Ireland (the "Central Bank") and it is possible that changes thereto may be necessary to meet the requirements of the Central Bank. The Management Company is of the opinion that there is nothing contained in this notice nor in the proposals detailed herein that conflicts with the Central Bank UCITS Regulations.

Key Points: 
  • The Management Company is of the opinion that there is nothing contained in this notice nor in the proposals detailed herein that conflicts with the Central Bank UCITS Regulations.
  • Philippe Ringard On behalf of JPMorgan Asset Management (Europe) S. r.l.
  • Please note that JPMorgan Asset Management is currently consolidating the listing of certain ETFs on Cboe Europe and effective Friday 30 July 2021 (the "Change Date"), after the close of the respective exchanges, the below ETF Share Classes will be switched from their current listing on Cboe Europe - UK trading venue (CXE) to Cboe Europe - NL trading venue (DXE).
  • Registered office 200 Capital Dock, 79 Sir John Rogerson's Quay
    Management Company JPMorgan Asset Management (Europe) S. r.l.

Staffing 360 Solutions Announces $7.58 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules

Retrieved on: 
Wednesday, July 21, 2021

The Company has also agreed to issue to the investors unregistered warrants to purchase up to an aggregate of 1,099,566 shares of common stock.

Key Points: 
  • The Company has also agreed to issue to the investors unregistered warrants to purchase up to an aggregate of 1,099,566 shares of common stock.
  • The offering is expected to close on or about July 23, 2021, subject to satisfaction of customary closing conditions.
  • Staffing 360 Solutions, Inc. is engaged in the execution of an international buy-integrate-build strategy through the acquisition of domestic and international staffing organizations in the United States and United Kingdom.
  • Staffing 360 Solutions does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law.

Bridgeline Receives More than $7.3M in Warrant Exercises

Retrieved on: 
Wednesday, July 21, 2021

WOBURN, Mass., July 21, 2021 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), provider of cloud-based marketing technology software, announced today it has received over $7.3M in cash, including the $2.5M previously disclosed, as a result of the recent warrant exercises.

Key Points: 
  • WOBURN, Mass., July 21, 2021 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), provider of cloud-based marketing technology software, announced today it has received over $7.3M in cash, including the $2.5M previously disclosed, as a result of the recent warrant exercises.
  • These warrants were originally issued in 2019 with a strike price of $4.00.
  • These funds bring Bridgelines cash balance to more than $9M with 8,393,609 shares of common stock outstanding.
  • Bridgeline helps companies grow online revenues by increasing their traffic, conversion rates, and average order values with its marketing platform and suite of apps.

Denarius Announces Listing of Warrants on the TSXV

Retrieved on: 
Tuesday, July 20, 2021

TORONTO, July 20, 2021 (GLOBE NEWSWIRE) -- Denarius Silver Corp. (“Denarius” or the “Company”) (TSXV: DSLV), is pleased to announce that the TSX Venture Exchange (the “TSXV”) has accepted for listing the 75,000,000 common share purchase warrants of the Company (the “Warrants”) for trading on the TSXV. The Warrants were previously issued on April 29, 2021 in connection with a non-brokered private placement of subscription receipts completed by the Company on March 17, 2021. Each Warrant entitles the holder to purchase one common share in the capital of the Company at a price of $0.80 until March 17, 2026. The Warrants were issued pursuant to, and are governed by, a warrant indenture between the Company and Computershare Trust Company of Canada dated April 29, 2021.

Key Points: 
  • TORONTO, July 20, 2021 (GLOBE NEWSWIRE) -- Denarius Silver Corp. (Denarius or the Company) (TSXV: DSLV), is pleased to announce that the TSX Venture Exchange (the TSXV) has accepted for listing the 75,000,000 common share purchase warrants of the Company (the Warrants) for trading on the TSXV.
  • The Warrants were previously issued on April 29, 2021 in connection with a non-brokered private placement of subscription receipts completed by the Company on March 17, 2021.
  • The Warrants were issued pursuant to, and are governed by, a warrant indenture between the Company and Computershare Trust Company of Canada dated April 29, 2021.
  • The Warrants are expected to commence trading on the TSXV at the open of markets on July 23, 2021 under the trading symbol DSLV.WT.

Black Spade Acquisition Co Announces Closing of $150 Million Initial Public Offering

Retrieved on: 
Tuesday, July 20, 2021

HONG KONG, July 20, 2021 /PRNewswire/ -- Black Spade Acquisition Co (the "Company") today announced the closing of its initial public offering of 15,000,000 units at a price of $10.00 per unit. The units began trading on the New York Stock Exchange (the "NYSE") under the ticker symbol "BSAQU" beginning July 16, 2021. Each unit consists of one of the Company's Class A ordinary shares and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Company expects that its Class A ordinary shares and warrants will be listed on the NYSE under the symbols "BSAQ" and "BSAQWS," respectively.

Key Points: 
  • HONG KONG, July 20, 2021 /PRNewswire/ --Black Spade Acquisition Co (the "Company") today announced the closing of its initial public offering of 15,000,000 units at a price of $10.00 per unit.
  • The units began trading on the New York Stock Exchange (the "NYSE") under the ticker symbol "BSAQU" beginning July 16, 2021.
  • Each unit consists of one of the Company's Class A ordinary shares and one-half of one redeemable warrant.
  • Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share.

Blue Star Gold Announces Closing of Final Tranche of Non-Brokered Private Placement, Conversion of Debt and Cancellation of Warrants

Retrieved on: 
Tuesday, July 20, 2021

The Company intends to use the net proceeds from the Private Placement for exploration and development of the Company's projects in Nunavut and for general working capital.

Key Points: 
  • The Company intends to use the net proceeds from the Private Placement for exploration and development of the Company's projects in Nunavut and for general working capital.
  • Additionally, the Company announces that on July 12, 2021, a total of 7,850,000 warrants (the "Warrants") were voluntarily cancelled by certain Warrant holders.
  • About Blue Star Gold Corp.
    Blue Star is a gold company focused on exploration and development within Nunavut, Canada.
  • Blue Star is listed on the TSX Venture Exchange under the symbol: BAU and on the Frankfurt Exchange under the symbol: 5WP.